Tag: DAWNA-1

Dalpiciclib benefits patients with HR-positive, HER2-negative advanced breast cancer

Presented By

Prof. Binghe Xu, Chinese Academy of Medical Sciences and Peking Union Medical College, China

Trial

Phase 3, DAWNA-1

Conference

ASCO 2021

Type

Peer-reviewed article